# UCLA Clinical Translational Science Institute

> **NIH NIH UL1** · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2020 · $9,648,639

## Abstract

Contact PD/PI: Dubinett, Steven M.
OVERALL
PROJECT SUMMARY/ABSTRACT
The UCLA Clinical and Translational Science Institute is a research partnership of UCLA-Westwood, Cedars-
Sinai Medical Center, Charles R. Drew University of Medicine and Science and the Los Angeles Biomedical
Institute at Harbor UCLA Medical Center. Its mission is to bring biomedical innovations to bear on the greatest
health needs of Los Angeles—the largest and one of the most ethnically, socially and economically diverse
counties in the United States. In doing so, our goal is to become a leading contributor in the CTSA Consortium
and speed scientific translation to benefit the nation as a whole. The CTSI has five aims: (1) Prepare the
translational workforce to conduct high-quality, multidisciplinary team science; (2) Engage stakeholder
communities in clinical and translational research and disseminate successful models of
collaboration; (3) Integrate special populations, especially those experiencing health disparities, into
research; (4) Improve methods and processes to accelerate scientific translation, overcome key
roadblocks and support multisite research; (5) Provide informatics solutions to operational and
scientific roadblocks to advance high-impact translational science within the UCLA CTSI and the CTSA
network. Our novel infrastructure includes: The Los Angeles Data Resource (LADR), a federation of clinical
data warehouses from six Los Angeles institutions; its governance agreement serves as the model for the
CTSA ACT initiative; an Innovation and Implementation Core with Los Angeles County, a laboratory for testing
approaches for improving care for the nearly 700,000 people annually treated in the county health system; a
Precision Medicine program that forms the infrastructure to bring genomic-level diagnosis to translational
investigation and clinical care across our UCLA Hub, multiple CTSAs and partner institutions; a training
program that integrates entrepreneurship principles in on-the-job training experiences in which investigators
are guided to utilize their own findings as they bring their discoveries to products. We propose to transform our
CTSI from a high-functioning service organization into a well-integrated research accelerator that will develop,
demonstrate and disseminate novel solutions to translational roadblocks, to the ultimate benefit of the Los
Angeles community, our region and the nation.
Project Summary/Abstract Page 745
Contact PD/PI: Dubinett, Steven M.
OVERALL

## Key facts

- **NIH application ID:** 9996817
- **Project number:** 5UL1TR001881-05
- **Recipient organization:** UNIVERSITY OF CALIFORNIA LOS ANGELES
- **Principal Investigator:** Steven M. Dubinett
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $9,648,639
- **Award type:** 5
- **Project period:** 2016-07-01 → 2022-06-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9996817

## Citation

> US National Institutes of Health, RePORTER application 9996817, UCLA Clinical Translational Science Institute (5UL1TR001881-05). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/9996817. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*